Research
Drug-Eluting Stents versus Coated Stents in Diabetic Patients with Acute Coronary Syndrome
Author(s): Ahmed Alsherif, Mohamed Ashraf, Ayman Moharram, Mahmoud Khaled* and Ahmed Rostom
Background: The term Acute Coronary Syndrome (ACS) is a term that describes the acute phase of ischemic coronary artery disease whether myocardial cell necrosis happens or not. Objective: To compare coated stents and drug-eluting stents in terms of Major Adverse Cardiac Events (MACE) and Instent Restenosis (ISR) rate. Patients and methods: A prospective, comparative, controlled, single-center study was conducted on forty diabetic patients diagnosed as NSTE-ACS with TIMI risk score ≥ 3, whose coronary angiography showed de novo CAD with ≥ 70% luminal stenosis to assess the influence of coated stent on the incidence of MACE and ISR after PCI in comparison with Drug-Eluting Stents (DES) in high-risk patients with ACS. Patients were divided into 2 groups according to the type of the stent; coated stent (titan 2) for group (A) and DES (Xience) for the group (B). MACE was reported dur.. Read More»
DOI:
O
Select your language of interest to view the total content in your interested language